Clearmind Medicine Inc.
CMNDDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Dec 2026
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Clearmind Medicine Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Clearmind Medicine Inc.'s (CMND) pipeline across Phase 2. Its lead program is Brequinar (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Clearmind Medicine Inc.'s next FDA catalyst?→
Clearmind Medicine Inc.'s (CMND) next tracked catalyst is a Phase 2 expected December 31, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CMND biotech catalysts?→
Add CMND to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Clearmind Medicine Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.